CompletedNot Applicable

Study of the Platelet Function During the Last Month of Pregnancy

France60 participantsStarted 2010-05

Plain-language summary

The objective is to compare women's platelet answer in the last month of pregnancy to women old enough to procreate, no pregnancy and without hormonal treatment. The hypothesis of research is that the decrease of platelet answer in pregnant women could not only limit the occurence of embolic accidents but also explain the lowest incidence of the arterial thrombosis in comparison with the venous thrombosis.

Who can participate

Age range18 Years – 50 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Signature of the form of consent * Absence of any physical or psychic pathology which can interfere with the normal realization of the study * Group1 : Women in the last month of pregnancy * Group 2 : Women old enough to procreate, no pregnancy and without hormonal treatment Exclusion Criteria: * Thrombopenia (platelet numeration \< 120 000 / mm3), * Gestational diabet, * Hormonal treatment : oestrogen-progestagen, progestagen, Selective Estrogen Receptor Modulator (SERM), inductors of ovulation, * Anticoagulant and any medication which can intervene on the platelet function (AINS, antidepressants) * Personal history of thromboembolic accident venous or arterial, * Personal history of haemostasis disease * Personal history of hepatic or renal disease * Personal history of autoimmune disease.

What they're measuring

surface covered by platelets

Timeframe: baseline

Volume of thrombies

Timeframe: baseline

Trial details

NCT IDNCT02828852

SponsorUniversity Hospital, Toulouse

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-07

View on ClinicalTrials.gov More Pregnancy trials